InvestorsHub Logo

msl2008

11/13/15 8:53 AM

#6298 RE: flyersdh #6297

It's good that you're missing the TRW trial so hopefully we get some upside.

Also, I think you're missing the 250k recurring royalty from J&J.

This has been a tough year for all of us. However, I don't really see any catalysts until March 2016 so in my opinion I think it'll be tough for us to move up until then. Thoughts?

yanquitrader

11/13/15 9:23 AM

#6299 RE: flyersdh #6297

To my eyes, Preview was excellent and very helpful. A big thanks for helping us during this admittedly painful stage of the company's development.

~ yanqui

edjohnson

11/13/15 12:52 PM

#6305 RE: flyersdh #6297

flyers, I am expecting the revenues for Q3 come in a little higher - somewhere between 5.5 and 6 million range, as I mentioned earlier. There are few items I believe you are missing.
So, I'm expecting MARA to beat Q3 revenue estimates.

As far as what the quarterly loss is going to be like? Well, you are conveniently omitting this in your article, just like the company does, but this is very important in this space. Case delays will keep draining the cash, and while you are seeing what these delays do to ACTG, effect to MARA will be a lot worse.

I gave my rough estimates of losses earlier, and there is a chance they could beat that too, but if the losses come in bigger, there is just no reason to continue to believe Croxall and Co.

Uniloc proxy should be available within a week, I believe. I wonder if they pushed the earnings release to Monday, because of that. I guess we'll find out.

Good luck.